Acer has to conduct new trial of rare disease drug, FDA says
Shares of the company fell dramatically Tuesday after it announced that the agency had rejected its application for the drug celiprolol in vascular Ehlers-Danlos syndrome.
Cambridge startup raises $2.1M to develop first drug for Maple Syrup Urine Disease
Cambridge startup Acer Therapeutics is developing the first therapy for a rare inherited condition called Maple Syrup Urine Disease. Known for causing neurological and social impairment, MSUD gets its unique name from the urine’s distinctive smell of maple syrup – all thanks to a defect in an individual’s amino acid metabolism. The company just raised $2.1 million, according […]
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.